Nyxoah Stock Today

NYXH Stock  USD 9.95  0.51  5.40%   

Performance

7 of 100

 
Weak
 
Strong
OK

Odds Of Distress

Less than 17

 
High
 
Low
Low
Nyxoah is trading at 9.95 as of the 6th of November 2024. This is a 5.40 percent increase since the beginning of the trading day. The stock's open price was 9.44. Nyxoah has less than a 17 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Nyxoah are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of October 2024 and ending today, the 6th of November 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
2nd of July 2021
Category
Healthcare
Classification
Health Care
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. Nyxoah S is traded on NASDAQ Exchange in the United States.. The company has 37.39 M outstanding shares of which 71.22 K shares are now shorted by private and institutional investors with about 0.45 trading days to cover. More on Nyxoah

Moving against Nyxoah Stock

  0.91APLS Apellis PharmaceuticalsPairCorr
  0.72MRK Merck Company Sell-off TrendPairCorr
  0.69KRYS Krystal BiotechPairCorr
  0.66CGEM Cullinan Oncology LLCPairCorr
  0.65LYRA Lyra TherapeuticsPairCorr
  0.6ANGO AngioDynamicsPairCorr

Nyxoah Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Thematic Ideas
(View all Themes)
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, BEL Small, NASDAQ Composite, BEL All Share, NASDAQ Health Care, Office Supplies, Furniture, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.03680.035
Sufficiently Up
Slightly volatile
Gross Profit Margin0.07250.0764
Notably Down
Slightly volatile
Total Current Liabilities8.6 M14.4 M
Way Down
Slightly volatile
Non Current Liabilities Total9.7 M11.7 M
Significantly Down
Slightly volatile
Total Assets94.2 M124.2 M
Way Down
Slightly volatile
Total Current Assets69 M68.4 M
Slightly Up
Slightly volatile
Debt Levels
Nyxoah can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Nyxoah's financial leverage. It provides some insight into what part of Nyxoah's total assets is financed by creditors.
Liquidity
Nyxoah currently holds 12.7 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Nyxoah has a current ratio of 7.1, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Nyxoah's use of debt, we should always consider it together with its cash and equity.

Net Borrowings

(737,865)
Nyxoah (NYXH) is traded on NASDAQ Exchange in USA. It is located in Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium, 1435 and employs 146 people. Nyxoah is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 362.53 M. Nyxoah conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 37.39 M outstanding shares of which 71.22 K shares are now shorted by private and institutional investors with about 0.45 trading days to cover. Nyxoah currently holds about 123.32 M in cash with (45.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77.
Check Nyxoah Probability Of Bankruptcy
Ownership Allocation
Nyxoah maintains a total of 37.39 Million outstanding shares. Nyxoah holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Nyxoah Ownership Details

Nyxoah Historical Income Statement

As of now, Nyxoah's Total Revenue is increasing as compared to previous years. The Nyxoah's current Gross Profit is estimated to increase to about 348.6 K, while Tax Provision is forecasted to increase to (312.6 K). View More Fundamentals

Nyxoah Stock Against Markets

Nyxoah Corporate Management

Jeremy FefferVP CommunicationProfile
Dorit NahariVP OperationsProfile
An MoonenGeneral CounselProfile
Francis KimChief OfficerProfile
Mikaela KirkwoodCorporate ManagerProfile
Loic MoreauChief OfficerProfile
When determining whether Nyxoah offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nyxoah's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nyxoah Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nyxoah Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nyxoah. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For more detail on how to invest in Nyxoah Stock please use our How to Invest in Nyxoah guide.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nyxoah. If investors know Nyxoah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nyxoah listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.61)
Revenue Per Share
0.164
Quarterly Revenue Growth
(0.30)
Return On Assets
(0.20)
Return On Equity
(0.37)
The market value of Nyxoah is measured differently than its book value, which is the value of Nyxoah that is recorded on the company's balance sheet. Investors also form their own opinion of Nyxoah's value that differs from its market value or its book value, called intrinsic value, which is Nyxoah's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nyxoah's market value can be influenced by many factors that don't directly affect Nyxoah's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nyxoah's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nyxoah is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nyxoah's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.